These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8131155)

  • 1. Serotonin receptor subtypes in depression: evidence from studies in neuroendocrine regulation.
    Cowen PJ
    Clin Neuropharmacol; 1993; 16 Suppl 3():S6-18. PubMed ID: 8131155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrinological responses to 5-HT.
    Cowen PJ; Anderson IM; Gartside SE
    Ann N Y Acad Sci; 1990; 600():250-7; discussion 257-9. PubMed ID: 2252313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanism by which the selective 5-HT1A receptor antagonist S-(-) UH 301 produces head-twitches in mice.
    Darmani NA; Reeves SL
    Pharmacol Biochem Behav; 1996 Sep; 55(1):1-10. PubMed ID: 8870031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin stimulates hypothalamic mRNA expression and local release of neurohypophysial peptides.
    Jørgensen H; Kjaer A; Knigge U; Møller M; Warberg J
    J Neuroendocrinol; 2003 Jun; 15(6):564-71. PubMed ID: 12716407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of serotonin receptor subtypes by nortriptyline and adinazolam in major depressive disorder: neuroendocrine and platelet markers.
    Stahl SM; Hauger RL; Rausch JL; Fleishaker JC; Hubbell-Alberts E
    Clin Neuropharmacol; 1993; 16 Suppl 3():S19-31. PubMed ID: 8131152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between 5-hydroxytryptamine receptor subtypes: is a disturbed receptor balance contributing to the symptomatology of depression in humans?
    Berendsen HH
    Pharmacol Ther; 1995 Apr; 66(1):17-37. PubMed ID: 7630928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of serotonin receptor subtypes in treating depression: a review of animal studies.
    Carr GV; Lucki I
    Psychopharmacology (Berl); 2011 Feb; 213(2-3):265-87. PubMed ID: 21107537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of somatodendritic 5-HT autoreceptors in modulating 5-HT neurotransmission.
    Blier P; Piñeyro G; el Mansari M; Bergeron R; de Montigny C
    Ann N Y Acad Sci; 1998 Dec; 861():204-16. PubMed ID: 9928258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in serotonergic responsiveness during cocaine withdrawal in rats: similarities to major depression in humans.
    Baumann MH; Rothman RB
    Biol Psychiatry; 1998 Oct; 44(7):578-91. PubMed ID: 9787882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Developments on Future Antidepressant-related Serotonin Receptors.
    Amidfar M; Kim YK
    Curr Pharm Des; 2018; 24(22):2541-2548. PubMed ID: 30073919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clarifications on the effects of 5-HT1A agonists and selective 5-HT reuptake inhibitors on the 5-HT system.
    Blier P; de Montigny C
    Neuropsychopharmacology; 1996 Aug; 15(2):213-6. PubMed ID: 8840358
    [No Abstract]   [Full Text] [Related]  

  • 12. Modulation of dialysate levels of dopamine, noradrenaline, and serotonin (5-HT) in the frontal cortex of freely-moving rats by (-)-pindolol alone and in association with 5-HT reuptake inhibitors: comparative roles of beta-adrenergic, 5-HT1A, and 5-HT1B receptors.
    Gobert A; Millan MJ
    Neuropsychopharmacology; 1999 Aug; 21(2):268-84. PubMed ID: 10432475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin receptors and neuroendocrine responses.
    Fuller RW
    Neuropsychopharmacology; 1990; 3(5-6):495-502. PubMed ID: 2078282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of serotonin 5-HT1B and 5-HT2A receptors suppresses the induction of locomotor activity by 5-HT reuptake inhibitors, citalopram and fluvoxamine, in NMRI mice exposed to a novel environment: a comparison to other 5-HT receptor subtypes.
    Millan MJ; Veiga S; Girardon S; Brocco M
    Psychopharmacology (Berl); 2003 Aug; 168(4):397-409. PubMed ID: 12721776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for serotonin receptor subtypes involvement in agmatine antidepressant like-effect in the mouse forced swimming test.
    Dias Elpo Zomkowski A; Oscar Rosa A; Lin J; Santos AR; Calixto JB; Lúcia Severo Rodrigues A
    Brain Res; 2004 Oct; 1023(2):253-63. PubMed ID: 15374751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoxetine-induced changes in body weight and 5-HT1A receptor-mediated hormone secretion in rats on a tryptophan-deficient diet.
    D'Souza DN; Zhang Y; Garcia F; Battaglia G; Van de Kar LD
    Am J Physiol Regul Integr Comp Physiol; 2004 Feb; 286(2):R390-7. PubMed ID: 14604841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex vivo inhibitory effect of the 5-HT uptake blocker citalopram on 5-HT synthesis.
    Moret C; Briley M
    J Neural Transm (Vienna); 1997; 104(2-3):147-60. PubMed ID: 9203078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonergic mechanisms and current and future psychiatric practice.
    Dubovsky SL; Thomas M
    J Clin Psychiatry; 1995; 56 Suppl 2():38-48. PubMed ID: 7844106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the neuroendocrine role of serotonin.
    Jørgensen HS
    Dan Med Bull; 2007 Nov; 54(4):266-88. PubMed ID: 18208678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of hippocampal 5-HT synthesis by fluoxetine and paroxetine: evidence for the involvement of both 5-HT1A and 5-HT1B/D autoreceptors.
    Barton CL; Hutson PH
    Synapse; 1999 Jan; 31(1):13-9. PubMed ID: 10025679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.